SECUADO is a Transdermal Film, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Noven Therapeutics, Llc. The primary component is Asenapine.
| Product ID | 68968-0173_584854cb-d9a5-44e0-adaa-50ebbad1c6e7 |
| NDC | 68968-0173 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SECUADO |
| Generic Name | Asenapine |
| Dosage Form | Film, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2020-02-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212268 |
| Labeler Name | Noven Therapeutics, LLC |
| Substance Name | ASENAPINE |
| Active Ingredient Strength | 6 mg/d |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-02-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212268 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-02-12 |
| Ingredient | Strength |
|---|---|
| ASENAPINE | 5.7 mg/d |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68968-0172 | SECUADO | ASENAPINE |
| 68968-0173 | SECUADO | ASENAPINE |
| 68968-0174 | SECUADO | ASENAPINE |
| 42794-016 | ASENAPINE | ASENAPINE |
| 42794-017 | ASENAPINE | ASENAPINE |
| 46708-198 | Asenapine | Asenapine |
| 46708-199 | Asenapine | Asenapine |
| 46708-544 | Asenapine | Asenapine |
| 62332-198 | Asenapine | Asenapine |
| 62332-199 | Asenapine | Asenapine |
| 62332-544 | Asenapine | Asenapine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SECUADO 87659437 5646398 Live/Registered |
HISAMITSU PHARMACEUTICAL CO., INC. 2017-10-25 |